Ordering
Available Variants1 mg
CHA.96622-1mg
Price
€792.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 mg | CHA.96622-1mg | €792.00 |
≥97% (HPLC), powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C151H226N40O45S3 |
|---|---|
| CAS Number | 21215-62-3 |
| Molecular Weight | 3417.85 |
| NACRES | NA.32 |
| PubChem Substance ID | 24900053 |
| UNSPSC Code | 51111800 |
| EC Number | 244-276-2 |
| MDL number | MFCD00167520 |
| Biological source | synthetic (organic) |
| Form | powder |
| Assay | ≥97% (HPLC) |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Calcitonin human, with a CAS number of 21215-62-3, is a peptide hormone produced by the thyroid gland in humans. It plays a crucial role in calcium and phosphorus metabolism, helping to regulate blood calcium levels by inhibiting osteoclast activity and promoting calcium deposition in bone. The hormone is composed of 32 amino acids and has a molecular weight of approximately 3432 Da. Calcitonin human is used therapeutically to treat conditions such as hypercalcemia, Pagets disease, and osteoporosis, where it helps to reduce bone resorption and increase bone density. Its mechanism of action involves binding to specific receptors on osteoclasts, resulting in a decrease in bone resorption and an overall reduction in blood calcium levels, making it a valuable therapeutic agent in the management of various bone-related disorders.
